BJP RCPsych Publications
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

The British Journal of Psychiatry (1966) 112: 633-636. doi: 10.1192/bjp.112.487.633
© 1966 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by EKDAWI, M. Y.
Right arrow Articles by FOWKE, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by EKDAWI, M. Y.
Right arrow Articles by FOWKE, R.

A Controlled Trial of Anti-Parkinson Drugs in Drug-Induced Parkinsonism

M. Y. EKDAWI M.B., Ch.B., D.P.M.1 and R. FOWKE M.B., Ch.B., D.P.M.1

1 Netherne Hospital, Coulsdon, Surrey

The action of a new anti-Parkinson drug, Tremonil (methixene hydrochloride) in drug-induced Parkinsonism was compared, in a controlled study on 57 chronic schizophrenic patients, with the effect of two established drugs. Although Tremonil had a slightly greater effect on tremor, the differences between the three drugs were slight, and were not statistically significant.

Submitted on October 15, 1965






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1966 The Royal College of Psychiatrists.